Latest filing published 22 Dec 2009 for MTS MEDICATION TECHNOLOGIES, INC /DE/.
No signal scores available.
John D. Stanton discloses dealings in MTS Medication Technologies, Inc /DE/ to SEC (Form 4). The record holds 3 filings, for trades running from 9 November 2007 to 22 December 2009.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 22 December 2009, reports a transaction in MTS Medication Technologies, Inc /DE/. Most trades are made public on the day they happen. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations